default author photo

Li Ren

Fudan University - Department of General Surgery

Shanghai, 200032

China

SCHOLARLY PAPERS

2

DOWNLOADS

136

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Bevacizumab Plus Chemotherapy versus Chemotherapy Alone As First-Line Treatment for Patients with RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Single Center Randomized Control Trial

Number of pages: 43 Posted: 29 Dec 2019
Fudan University - Department of General Surgery, Fudan University - Department of General Surgery, Fudan University - Department of Liver Surgery and Transplantation, Fudan University - Department of General Surgery, Fudan University - Department of General Surgery, Fudan University - Department of General Surgery, Fudan University - Department of Liver Surgery and Transplantation, Fudan University - Department of Radiology, Fudan University, Zhongshan Hospital, Department of Oncology, Fudan University, Zhongshan Hospital, Department of Oncology and Fudan University - Colorectal Cancer Center
Downloads 77 (823,616)

Abstract:

Loading...

Bevacizumab; RAS mutant; unresectable; colorectal liver-limited metastases

2.

RAS/BRAF Status Determines Treatment Efficacy and Prognosis of Metastatic Colorectal Cancer: A Real Word Analysis of 1002 Consecutive Cases

Number of pages: 36 Posted: 31 Mar 2021
Fudan University - Department of General Surgery, Fudan University - Colorectal Cancer Center, Fudan University - Colorectal Cancer Center, Fudan University - Colorectal Cancer Center, Fudan University - Colorectal Cancer Center, Fudan University - Colorectal Cancer Center, Fudan University - Colorectal Cancer Center, Fudan University - Colorectal Cancer Center, Fudan University - Colorectal Cancer Center, Fudan University - Department of General Surgery and Fudan University - Colorectal Cancer Center
Downloads 59 (1,010,164)

Abstract:

Loading...